Mineralocorticoid Receptor May Regulate Glucose Homeostasis through the Induction of Interleukin-6 and Glucagon-Like peptide-1 in Pancreatic Islets
Authors:
- Rieko GotoRGRieko Goto
- Tatsuya KondoTKTatsuya Kondo
- Kaoru OnoKOKaoru Ono
- Sayaka KitanoSKSayaka Kitano
- Nobukazu MiyakawaNMNobukazu Miyakawa
- Takuro WatanabeTWTakuro Watanabe
- Masaji SakaguchiMSMasaji Sakaguchi
- Miki SatoMSMiki Sato
- Motoyuki IgataMIMotoyuki Igata
- Junji KawashimaJKJunji Kawashima
- Hiroyuki MotoshimaHMHiroyuki Motoshima
- Takeshi MatsumuraTMTakeshi Matsumura
Open Access
- 14 May 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (5) , 674
Abstract
Because the renin-angiotensin-aldosterone system influences glucose homeostasis, the mineralocorticoid receptor (MR) signal in pancreatic islets may regulate insulin response upon glucose load. Glucagon-like peptide-1 (GLP-1) production is stimulated by interleukin-6 (IL-6) in pancreatic α-cells. To determine how glucose homeostasis is regulated by interactions of MR, IL-6 and GLP-1 in islets, we performed glucose tolerance and histological analysis of islets in primary aldosteronism (PA) model rodents and conducted in vitro experiments using α-cell lines. We measured active GLP-1 concentration in primary aldosteronism (PA) patients before and after the administration of MR antagonist eplerenone. In PA model rodents, aldosterone decreased insulin-secretion and the islet/pancreas area ratio and eplerenone added on aldosterone (E+A) restored those with induction of IL-6 in α-cells. In α-cells treated with E+A, IL-6 and GLP-1 concentrations were increased, and anti-apoptotic signals were enhanced. The E+A-treatment also significantly increased MR and IL-6 mRNA and these upregulations were blunted by MR silencing using small interfering RNA (siRNA). Transcriptional activation of the IL-6 gene promoter by E+A-treatment required an intact MR binding element in the promoter. Active GLP-1 concentration was significantly increased in PA patients after eplerenone treatment. MR signal in α-cells may stimulate IL-6 production and increase GLP-1 secretion, thus protecting pancreatic β-cells and improving glucose homeostasis.Keywords
Funding Information
- Japan Society for the Promotion of Science (17K09837)
This publication has 44 references indexed in Scilit:
- Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetesCardiovascular Diabetology, 2013
- Optimal Elevation of β-Cell 11β-Hydroxysteroid Dehydrogenase Type 1 Is a Compensatory Mechanism That Prevents High-Fat Diet–Induced β-Cell FailureDiabetes, 2012
- The renin–angiotensin–aldosterone system and glucose homeostasisTrends in Pharmacological Sciences, 2011
- Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine isletsDiabetologia, 2011
- Incretin responses to oral glucose load in Japanese non-obese healthy subjectsDiabetes Therapy, 2011
- Glucocorticoid use in acute lymphoblastic leukaemiaThe Lancet Oncology, 2010
- Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused ratsNephrology Dialysis Transplantation, 2010
- Regulation of Mineralocorticoid Receptor Expression during Neuronal Differentiation of Murine Embryonic Stem CellsEndocrinology, 2010
- Single plasmids expressing human steroid hormone receptors and a reporter gene for use in yeast signaling assaysPlasmid, 2009
- Glucagon-Like Peptide-1 Protects β-Cells Against Apoptosis by Increasing the Activity of an Igf-2/Igf-1 Receptor Autocrine LoopDiabetes, 2009